Literature DB >> 15607562

Could one of the most widely prescribed antibiotics amoxicillin/clavulanate "augmentin" be a risk factor for autism?

Joan Fallon1.   

Abstract

Autism is an ever increasing problem in the United States. Characterized by multiple deficits in the areas of communication, development, and behavior; autistic children are found in every community in this country and abroad. Recent findings point to a significant increase in autism which can not be accounted for by means such as misclassification. The state of California recently reported a 273% increase in the number of cases between 1987 and 1998. Many possible causes have been proposed which range from genetics to environment, with a combination of the two most likely. Since the introduction of clavulanate/amoxicillin in the 1980s there has been the increase in numbers of cases of autism. In this study 206 children under the age of three years with autism were screened by means of a detailed case history. A significant commonality was discerned and that being the level of chronic otitis media. These children were found to have a mean number 9.96 bouts of otitis media (with a standard error of the mean of +/-1.83). This represents a sum total for all 206 children of 2052 bouts of otitis media. These children received a mean number of 12.04 courses of antibiotics (standard error of the mean of +/-.125). The sum total number of courses of antibiotics given to all 206 children was 2480. Of those 893 courses were Augmentin. with 362 of these Augmentin courses administered under the age of one year. A proposed mechanism whereby the production of clavulanate may yield high levels of urea/ammonia in the child is presented. Further an examination of this mechanism needs to be undertaken to determine if a subset of children are at risk for neurotoxicity from the use of clavulanic acid in pharmaceutical preparations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607562     DOI: 10.1016/j.mehy.2004.06.023

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  18 in total

Review 1.  Environmental factors associated with autism spectrum disorder: a scoping review for the years 2003-2013.

Authors:  M Ng; J G de Montigny; M Ofner; M T Do
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-01       Impact factor: 3.240

2.  Impaired Spatial Cognition in Adult Rats Treated with Multiple Intracerebroventricular (ICV) Infusions of the Enteric Bacterial Metabolite, Propionic Acid, and Return to Baseline After 1 Week of No Treatment: Contribution to a Rodent Model of ASD.

Authors:  Jennifer R Mepham; Francis H Boon; Kelly A Foley; Donald P Cain; Derrick F MacFabe; Klaus-Peter Ossenkopp
Journal:  Neurotox Res       Date:  2019-03-08       Impact factor: 3.911

Review 3.  Do your gut microbes affect your brain dopamine?

Authors:  Camila González-Arancibia; Jocelyn Urrutia-Piñones; Javiera Illanes-González; Jonathan Martinez-Pinto; Ramón Sotomayor-Zárate; Marcela Julio-Pieper; Javier A Bravo
Journal:  Psychopharmacology (Berl)       Date:  2019-05-17       Impact factor: 4.530

4.  Otitis Media and Related Complications Among Children with Autism Spectrum Disorders.

Authors:  Daniel J Adams; Apryl Susi; Christine R Erdie-Lalena; Gregory Gorman; Elizabeth Hisle-Gorman; Michael Rajnik; Marilisa Elrod; Cade M Nylund
Journal:  J Autism Dev Disord       Date:  2016-05

5.  Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders.

Authors:  Derrick F MacFabe
Journal:  Microb Ecol Health Dis       Date:  2015-05-29

6.  Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.

Authors:  Richard E Frye; Shannon Rose; John Slattery; Derrick F MacFabe
Journal:  Microb Ecol Health Dis       Date:  2015-05-07

7.  GUT in FOCUS Symposium NOBEL FORUM, Karolinska Institutet, February 2nd 2015.

Authors: 
Journal:  Microb Ecol Health Dis       Date:  2015-05-29

8.  Early-life antibiotic use and risk of attention-deficit hyperactivity disorder and autism spectrum disorder: results of a discordant twin study.

Authors:  Elise M A Slob; Bronwyn K Brew; Susanne J H Vijverberg; Talitha Dijs; Catharina E M van Beijsterveldt; Gerard H Koppelman; Meike Bartels; Conor V Dolan; Henrik Larsson; Sebastian Lundström; Paul Lichtenstein; Tong Gong; Anke H Maitland-van der Zee; Aletta D Kraneveld; Catarina Almqvist; Dorret I Boomsma
Journal:  Int J Epidemiol       Date:  2021-05-17       Impact factor: 7.196

9.  Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.

Authors:  R E Frye; S Melnyk; D F Macfabe
Journal:  Transl Psychiatry       Date:  2013-01-22       Impact factor: 6.222

Review 10.  Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis.

Authors:  Alessandra Mezzelani; Martina Landini; Francesco Facchiano; Maria Elisabetta Raggi; Laura Villa; Massimo Molteni; Barbara De Santis; Carlo Brera; Anna Maria Caroli; Luciano Milanesi; Anna Marabotti
Journal:  Nutr Neurosci       Date:  2014-01-21       Impact factor: 4.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.